Effect of pharmacological agents on exercise testing and exercise training of the coronary patient.
Many cardiovascular drugs can significantly alter the exercise capacity of patients with symptomatic atherosclerotic coronary heart disease. The effects of specific pharmacological agents and of regiments of combined drug therapy on the results of exercise testing and in relation to exercise training warrant careful consideration.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000959:Antihypertensive Agents / Q000494:pharmacology; D002121:Calcium Channel Blockers / Q000494:pharmacology; D002317:Cardiovascular Agents / Q000494:pharmacology*; D003327:Coronary Disease / Q000188:drug therapy / Q000503:physiopathology / Q000534:rehabilitation*; D004071:Digitalis Glycosides / Q000494:pharmacology; D005080:Exercise Test; D005081:Exercise Therapy; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D009200:Myocardial Contraction / Q000187:drug effects; D009566:Nitrates / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D002317:Cardiovascular Agents; D004071:Digitalis Glycosides; D009566:Nitrates; D014665:Vasodilator Agents